We establish that CD4+ T cells are the primary cells driving meta-inflammation via TNF-α in T2DM patients through STAT3 and provide an inclusive characterization of chronic low-grade inflammation in T2DM patients. This evidence concerns the gene STAT3 and type 2 diabetes mellitus.